Durvalumab for the Management of Urothelial Carcinoma: A Short Review on the Emerging Data and Therapeutic Potential
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s141040
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Informa UK Limited